Pain relief after knee arthroscopy surgery. Acute pain
Conditions
Interventions
Intervention 1: The first intervention group receives 0.20% (10 mL) bupivacaine intra articularly. Intervention 2: The seccond intervention group receives bupivacaine 0.20% and 1 g of magnesium sulfat
Prevention
Placebo
The first intervention group receives 0.20% (10 mL) bupivacaine intra articularly
The seccond intervention group receives bupivacaine 0.20% and 1 g of magnesium sulfate in 10 ml salin solution intra articualrly
The third intervention group receives 10 mL of isotonic saline intra articularly
Sponsors
Ahvaz Jondishapoor University of Medical Sciences
Eligibility
Sex/Gender
All
Age
18 Years to 60 Years
Inclusion criteria
Inclusion criteria: Inclusion criteria: patients' age between 18 to 60 years and patients having ASA class 1 or 2 Exclusion criteria: having contraindication for spinal anesthesia or refuse spinal anesthesia; patients with chronic pain or allergy to local anesthetics and patients with history of chronic analgesic use (nonsteroidal anti-inflammatory drugs, opioids, or paracetamol)
Exclusion criteria
Exclusion criteria:
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| Pain. Timepoint: 4, 6, 8, 12 and 24 hours after. Method of measurement: Numeric rating scale. | — |
Secondary
| Measure | Time frame |
|---|---|
| Pethedine consumpsion. Timepoint: 4, 6, 8, 12 and 24 hours post operation. Method of measurement: Medical records. | — |
Countries
Iran (Islamic Republic of)
Contacts
Public ContactDr. Mohamad Reza Pipelzadeh
Ahvaz Jondishapoor University of Medical Sciences
Outcome results
None listed